Targeting Androgen Receptor Action for Prostate Cancer Treatment: Does the Post-Receptor Level Provide Novel Opportunities?

The standard of care for patients who suffer from non-organ confined prostate cancer (CaP) is androgen deprivation therapy (ADT). ADT exploits the reliance of CaP cells on androgen receptor (AR) signaling throughout CaP progression from androgen-stimulated (AS) to castration-recurrent (CR) disease....

Descripción completa

Detalles Bibliográficos
Autor principal: Heemers, Hannelore V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062950/
https://www.ncbi.nlm.nih.gov/pubmed/24948870
http://dx.doi.org/10.7150/ijbs.8479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062950/
https://www.ncbi.nlm.nih.gov/pubmed/24948870
http://dx.doi.org/10.7150/ijbs.8479

Ejemplares similares